These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3390495)

  • 41. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Saliva cortisol levels following dexamethasone administration in endogenously depressed patients.
    Poland RE; Rubin RT
    Life Sci; 1982 Jan; 30(2):177-81. PubMed ID: 7054643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personality traits and monoamine oxidase activity in platelets in depressed patients.
    Perris C; Eisemann M; von Knorring L; Oreland L; Perris H
    Neuropsychobiology; 1984; 12(4):201-5. PubMed ID: 6535064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low levels of somatostatin in human CSF mark depressive episodes.
    Agren H; Lundqvist G
    Psychoneuroendocrinology; 1984; 9(3):233-48. PubMed ID: 6149588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet MAO activity in posttraumatic stress disorder.
    Davidson J; Lipper S; Kilts CD; Mahorney S; Hammett E
    Am J Psychiatry; 1985 Nov; 142(11):1341-3. PubMed ID: 4061693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of whole blood serotonin and platelet MAO in children with schizophrenia and major depressive disorder.
    Rogeness GA; Mitchell EL; Custer GJ; Harris WR
    Biol Psychiatry; 1985 Mar; 20(3):270-5. PubMed ID: 3978162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of oral contraceptives on platelet monoamine oxidase, monoamine excretion, and adrenocortical function.
    Feldman JM; Roche J
    Clin Pharmacol Ther; 1976 Dec; 20(6):670-5. PubMed ID: 991538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of isocarboxazid on platelet MAO activity.
    Davidson J; White H
    Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
    [No Abstract]   [Full Text] [Related]  

  • 53. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered platelet monoamine oxidase activity in affective disorders.
    Mann J
    Psychol Med; 1979 Nov; 9(4):729-36. PubMed ID: 515270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic subgrouping of depressed patients by principal component analysis and visualized pattern recognition.
    Wahlund B; Sääf J; Grahn H; Wetterberg L
    Psychiatry Res; 1998 Dec; 81(3):393-401. PubMed ID: 9925191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoamine oxidase activity in blood platelets from manic and depressed patients.
    Takahashi S
    Folia Psychiatr Neurol Jpn; 1977; 31(1):37-48. PubMed ID: 863345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does the dexamethasone suppression test have clinical utility in psychiatry?
    Baldessarini RJ; Arana GW
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):25-9. PubMed ID: 3968053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet monoamine oxidase activity in obsessive-compulsive disorder.
    Arrojo M; Baca-Garcia E; Perez-Rodriguez MM; Dolengevich-Segal H; Navio-Acosta M; Rodriguez-Salgado B; Saiz-Ruiz J
    Eur Psychiatry; 2007 Nov; 22(8):525-9. PubMed ID: 17761404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the connections between platelet monoamine oxidase activity and behavior: relationships with performance in neuropsychological tasks.
    af Klinteberg B; Oreland L; Hallman J; Wirsén A; Levander SE; Schalling D
    Neuropsychobiology; 1990-1991; 23(4):188-96. PubMed ID: 2130288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet monoamine oxidase in affective disorders.
    Edwards DJ; Spiker DG; Kupfer DJ; Foster G; Neil JF; Abrams L
    Arch Gen Psychiatry; 1978 Dec; 35(12):1443-6. PubMed ID: 727880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.